Landscapes / Companies
Glaukos Corporation not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 approved
1 in Phase 3
Drugs
6
in active trials · 16 in all
Trials
8 active
29 since 2021
Drugs6
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Approved | May 2027Phase 4 trial completes | |||
| Next date | May 2027 · Phase 4 trial completes | ||||
| Also tested for | Glaucoma, Open-Angle, Ocular Hypertension (OHT) and 1 more | ||||
| Open drug page | |||||
— |
Approved | Sep 2027Phase 4 trial completes | |||
| Next date | Sep 2027 · Phase 4 trial completes | ||||
| Also tested for | Keratoconus | ||||
| Open drug page | |||||
— |
Phase 3 | Mar 2028Phase 2 trial completes | |||
| Next date | Mar 2028 · Phase 2 trial completes | ||||
| Also tested for | Glaucoma | ||||
| Open drug page | |||||
— |
Phase 2 | Apr 2027Phase 2 trial completes | |||
| Next date | Apr 2027 · Phase 2 trial completes | ||||
| Also tested for | Keratoconus | ||||
| Open drug page | |||||
— |
Phase 2 | — | |||
| Also tested for | Demodex Blepharitis | ||||
| Open drug page | |||||
— |
Phase 2 | — | |||
| Also tested for | Persistent Corneal Epithelial Defect | ||||
| Open drug page | |||||
About
- No active trial
- 10 other drugs
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021